Publications

Scholarly Journals--Published

  • Comparison of antimicrobial dosing recommendations in patients receiving intermittent hemodialysis among drug information resources (12/2021) (link)
  • Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy   (09/2021) (link)
  • Jang SM, Awdishu L. Drug dosing consideration for critically ill patients receiving continuous renal replacement therapy. Sem in Dial. 2021. (05/2021) (link)
  • Jang SM, Bahjri K, Lee JY, Nabavi S, Abdi Pour A. Use of Angiotensin Converting Enzyme Inhibitors in Patients Receiving Therapeutic Plasma Exchange with Centrifuge-based Apheresis System. Ther Apher Dial. 2020. doi: 10.1111/1744-9987.13589. (11/2020)
  • Jang SM, Parker WM, Pai AB, Jiang R, Cardone KE. Assessment of Literacy and Numeracy Skills Related to Medication Labels in Patients on Chronic In-Center Hemodialysis. J Am Phar Assoc. https://doi.org/10.1016/j.japh.2020.07.010. (11/2020)
  • Jang SM, Anam S, Pringle T, Lahren P, Infante S. Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases. Pharmacy. 2020.  (11/2020)
  • Jang SM, Bahjri K, Tran H. Safety and efficacy of direct oral anticoagulants for atrial fibrillation in patients with renal impairment. Pharmacy. 2020. (11/2020)
  • Jang SM, Lewis SJ, Mueller BA. Harmonizing antibiotic regimens with renal replacement therapy. Expert Rev Anti Infect Ther. 2020;18;1-9. (09/2020)
  • Jang SM, Parker WM, Pai AB, Jiang R, Cardone KE. Assessment of Literacy and Numeracy Skills Related to Medication Labels in Patients on Chronic In-Center Hemodialysis. J Am Phar Assoc (2003). 2020; S1544-3191(20):30330-7. (07/2020)
  • Jang SM, Infante S, Abdi Pour A. Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. Pharmacy 2020, 8(1), 18; https://doi.org/10.3390/pharmacy8010018 (02/2020) (link)
  • Jang SM, Pai MP, Shaw AR, Mueller BA. Antibiotic exposure profiles in trials comparing intensity of continuous renal replacement therapy. Crit Care Med. 2019;47(11):e863-e871. (11/2019) (link)
  • Jang SM, Jiang R, Grabe D, Pai AB. Assessment of literacy and numeracy skills related to non-steroidal anti-inflammatory drug labels. SAGE Open Med. 2019. doi: 10.1177/2050312119834119. (03/2019) (link)
  • Update on preparation of solutions for continuous renal replacement therapy (07/2018) (link)
  • Jang SM, Gharibian KN, Lewis SJ, Fissell WH, Tolwani AJ, Mueller BA. Beta lactam Dosing Predictions in Critically Ill Patients Receiving Daily Prolonged Intermittent Renal Replacement Therapy: A Monte Carlo Simulation Approach. J Clin Pharm. 2018. https://doi.org/10.1002/jcph.1137. (06/2018) (link)
  • Jang SM, Hough G, Mueller BA. Ex Vivo Rizafungin Adsorption and Clearance During Continuous Hemofiltration. Blood Purif. 2018. 2018;46:214–219 (06/2018) (link)
  • Lee JS, Kang JE, Park SH, Jang SM, Kim SA, Rhie SJ. Nutritional and Clinical Outcomes of Nutritional Support in Multidisciplinary team for Critically Ill Patients.Nutrition Clin Prac. 2018. DOI: 10.1002/ncp.10093. (05/2018) (link)
  • Iron-based phosphate binders--a new element in management of hyperphosphatemia (08/2016) (link)
  • Pai AB, Jang SM, Wegrzyn N. Iron-based Phosphate Binders - a New Element in Management of Hyperphosphatemia. Expert Opin Drug Metab Toxicol. 2015 Nov 16:1-13. (06/2016) (link)
  • Parker WM, Jang SM, Muzzy JD, Cardone KE. Multidisciplinary Views toward Pharmacist-Delivered MTM Services in Dialysis Facilities. J Am Pharm Assoc. 2015; 55(4):390-7. (07/2015) (link)
  • Jang SM, Cerulli J, Grabe DW, Fox C, Vassalotti J, Prokopienko AJ, Pai AB. Community Pharmacy-based NSAID Avoidance Education for High-Risk Patients to Prevent Acute Kidney Injury. Prev Chronic Dis. 2014; 11: E220. (12/2014) (link)
  • Jang SM, Cardone KE, Nolin TD, Mason DL, Grabe DW. Determination of Vancomycin and Gentamicin Clearance in an In Vitro, Closed Loop Hemodialysis System. BMC Nephrol. 2014 Dec 20;15(1):204 (12/2014) (link)

Books and Chapters

  • Khan AM, Digiantonio N, Hankins CL, Jang SM. Drug Dosing in Diaysis. Pharmacotherapy Self-Assessment Program (PSAP). Lenexa, KS: The American College of Clinical Pharmacy, 2019. (08/2019)
  • Jang SM, Mueller BA. Dosing Considerations for Patients with AKI and CRRT, Renal/Pulmonary Critical Care Module in Critical Care Self-Assessment Program (CCSAP).  Lenexa, KS: American College of Clinical Pharmacy, 2017. (05/2017)